What is the first line of treatment at home for a patient with bronchial asthma in acute exacerbation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 30, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Home Medication for Acute Asthma Exacerbation

For acute asthma exacerbation at home, immediately administer nebulized salbutamol 5 mg (or terbutaline 10 mg) OR 4-8 puffs of albuterol via metered-dose inhaler with spacer, combined with oral prednisolone 30-60 mg, and reassess response within 15-30 minutes. 1, 2

Initial Assessment Before Treatment

Assess severity objectively—do not rely on clinical impression alone, as underestimation is a critical and common pitfall 1, 2:

  • Speech ability: Can the patient complete sentences? 1
  • Respiratory rate: >25 breaths/min indicates severe exacerbation 1
  • Heart rate: >110 beats/min suggests severity 1
  • Peak expiratory flow (PEF): <50% predicted/best indicates acute severe asthma 1

First-Line Treatment Protocol

Bronchodilator Administration

Option 1 - Nebulizer (Preferred if available):

  • Salbutamol 5 mg OR terbutaline 10 mg via nebulizer 1, 2
  • If no nebulizer available, proceed to Option 2 1

Option 2 - Metered-Dose Inhaler with Spacer:

  • Give 2 puffs of β-agonist via large volume spacer, repeat 10-20 times (total 4-8 puffs minimum) 1
  • This method is equally effective when properly administered 2

Systemic Corticosteroids (Essential - Do Not Delay)

Administer immediately, not after "trying bronchodilators first" 1, 2:

  • Adults: Prednisolone 30-60 mg orally as single dose 1, 2, 3
  • Children: Prednisolone 1-2 mg/kg (maximum 40-60 mg) 1, 2, 3
  • Clinical benefits require 6-12 hours minimum to manifest, making early administration crucial 2, 3

Reassessment at 15-30 Minutes

This step is mandatory before leaving the patient 1:

If PEF >50-75% predicted/best:

  • Continue prednisolone 30-60 mg daily 1
  • Step up usual maintenance treatment 1
  • Arrange surgery/clinic review within 48 hours 1
  • Provide self-management plan and PEF monitoring chart 1

If PEF remains <50% or severe features persist:

  • Arrange immediate hospital admission 1
  • Repeat nebulized salbutamol OR give additional MDI puffs 1
  • Consider adding ipratropium 0.5 mg to nebulizer 1, 2
  • Oxygen 40-60% if available during transport 1

Critical Pitfalls to Avoid

  • Never delay corticosteroid administration—underuse of corticosteroids is a documented cause of preventable asthma deaths 1, 2
  • Never administer sedatives of any kind to patients with acute asthma 1, 2
  • Do not underestimate severity—always measure PEF objectively rather than relying on clinical impression 1, 2
  • Do not use SABA alone without considering systemic corticosteroids for moderate-to-severe exacerbations 2

Hospital Admission Criteria

Immediate referral required if any of the following present 1:

  • Any life-threatening features (confusion, silent chest, cyanosis, PEF <33%) 1
  • Features of acute severe asthma persist after initial treatment 1
  • Attack occurs in afternoon/evening 1
  • Recent hospital admission or previous severe attacks 1
  • Patient unable to assess own condition or concerning social circumstances 1

Follow-Up Requirements

  • Within 48 hours: Surgery review for mild-moderate exacerbations 1
  • Within 24 hours: Surgery review for severe exacerbations that improved 1
  • Continue prednisolone 30-60 mg daily for 5-10 days total 2, 3
  • No tapering necessary for courses <10 days, especially if on inhaled corticosteroids 2, 3
  • Monitor symptoms and PEF on chart daily 1
  • Modify treatment according to chronic asthma guidelines at review 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Asthma Exacerbation Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Corticosteroid Dosing for Asthma Exacerbations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.